Brian Dakin, PMP, CIPM, is a seasoned leader in project management, data privacy, and technology solutions within the life sciences industry. As the Principal of Rhombus Consulting, he has driven strategic initiatives that enhance operational efficiency, regulatory compliance, and data governance for pharmaceutical and biotechnology organizations. In his role as President and Head of Operations for a trusted third-party entity, he has led efforts in patient de-identification, achieving HIPAA and SOC2 Type 2 compliance while increasing revenue and profitability. A thought leader and member of the Forbes Coaches Council, Brian also developed **On The Ball Theory**, a framework designed to help individuals unlock their potential and achieve meaningful personal and professional goals. His extensive experience, combined with his commitment to innovation and mentorship, has positioned him as an influential figure in both corporate leadership and personal development.

I am excited to share my executive biography, highlighting my journey in oncology, clinical research, and medical affairs over the past 25 years. From my work as a medical science liaison to my leadership in pharmacy education and healthcare consulting, I have been committed to advancing patient care, scientific innovation, and medical education. If you're interested in learning more about my background, expertise, and contributions to pharmaceutical sciences and healthcare strategy.

Elizabeth M. Troll is a seasoned executive with over 42 years of global leadership in quality assurance, regulatory compliance, and governance within the pharmaceutical, biopharmaceutical, and healthcare industries. Renowned for her expertise in Quality Management Systems (QMS), vendor oversight, inspection readiness, and leadership development, Liz has played a pivotal role in shaping compliance frameworks that align regulatory standards with business efficiency. She has led quality and compliance initiatives at Endpoint Clinical, Novan Inc., QuintilesIMS, and Otsuka, driving strategic improvements and fostering a culture of operational excellence. A dynamic speaker and mentor, Liz is passionate about developing future leaders, advancing industry best practices, and supporting organizations in achieving regulatory success. With a strong commitment to integrity, respect, and continuous improvement, she seeks to leverage her expertise through board service and advisory roles, helping companies navigate complex regulatory landscapes and drive sustainable growth.

Maryam Nourbakhsh is a seasoned project management leader with over 18 years of experience in the pharmaceutical and healthcare industries, specializing in strategic operations, clinical quality, and global regulatory compliance. She has a proven track record of driving complex initiatives, optimizing resource allocation, and implementing data-driven decision-making frameworks to enhance portfolio planning and operational efficiency. Currently serving as Director of Project Management at Bristol Myers Squibb, she spearheads innovative methodologies, fosters cross-functional collaboration, and ensures alignment with corporate objectives. With expertise spanning oncology, immunology, and hematology, Maryam has successfully led high-impact projects at leading pharmaceutical organizations, leveraging her knowledge in clinical trials, governance structures, and process improvement. Holding an MBA in Pharmaceutical Marketing and certifications in Lean Six Sigma and Change Management, she is a strategic thinker committed to innovation, operational excellence, and fostering a culture of continuous improvement.

Ryan K. Stansfield is a seasoned leader with over 23 years of experience in small molecule drug discovery and development. Currently serving as Director of DMPK-Toxicology at 858 Therapeutics, he has successfully led teams through critical phases of drug development, including managing IND-enabling toxicology studies and building high-performing scientific teams. Stansfield is recognized for his deep expertise in ADME, safety pharmacology, and toxicology, as well as his strategic ability to drive projects from discovery to clinical trials. Throughout his career, he has demonstrated exceptional communication skills, collaborating across functions and ensuring timely, rigorous data to support regulatory submissions. With a proven track record in managing budgets, experimental design, and in-licensing diligence, Stansfield has contributed to the successful advancement of multiple therapeutic candidates.

Matthew Smollin, PharmD, is an accomplished leader in medical affairs and clinical innovation with over 15 years of clinical experience and a decade of industry expertise spanning clinical research, regulatory strategy, and team leadership. As Vice President of Medical Affairs at Karius, Inc., he directs medical and scientific strategies, guiding breakthrough advancements in molecular diagnostics while navigating complex FDA and Medicare regulatory processes. Throughout his career, he has successfully built and managed high-performing teams, fostered strong relationships with key opinion leaders, and played a pivotal role in clinical trial design, publication strategy, and scientific engagement. A respected speaker and thought leader, Dr. Smollin’s expertise in infectious disease diagnostics and next-generation sequencing has shaped industry best practices and advanced clinical innovation. His dedication to scientific excellence, strategic vision, and ability to translate complex medical insights into impactful solutions make him a driving force in the evolution of precision medicine and diagnostic technologies.

I’m excited to share my executive biography, detailing my 34-year journey in finance, accounting, and business transformation across the pharmaceutical, clinical research, and healthcare industries. I’m passionate about leading change, building trust, and driving financial excellence. If you’re looking for strategic board leadership in finance and operations, let’s connect!

Excited to share my professional executive biography! With over 20 years of experience in biotech program management, drug development, and regulatory strategy, I have had the privilege of leading cross-functional teams, guiding early-stage startups, and ensuring successful clinical execution. If you're looking for strategic leadership, operational excellence, and industry expertise, I’d love to connect and explore opportunities to collaborate.

Paul Sieben is a dynamic executive leader with over five decades of experience driving business growth, operational excellence, and strategic transformation across healthcare, construction, and automation industries. A visionary strategist, he has successfully scaled companies, optimized financial performance, and guided organizations through complex transitions. With a deep expertise in stakeholder relations, P&L management, and risk mitigation, Paul has played a pivotal role in high-growth enterprises and board leadership. His ability to foster innovation, build strong teams, and navigate change makes him an invaluable asset to organizations seeking sustainable success. Currently serving on multiple boards, Paul is actively pursuing additional opportunities to leverage his expertise in governance, strategy, and business development.

After an incredible career in pharmaceutical sales, biotechnology, and market access, I’m excited to share my executive biography. With over 35 years of experience leading high-performing teams, driving business growth, and shaping strategic sales initiatives, I remain passionate about mentoring, leadership development, and business strategy. I look forward to new opportunities to contribute my expertise and continue making an impact. Here is my biography.

I’m thrilled to share my executive biography, highlighting my experience in driving growth, operational excellence, and innovation within the biotech and pharmaceutical industries. From building startup companies to leading transformative clinical and operational strategies, I’ve had the privilege of contributing to life-changing advancements.

Peter Payne is a highly accomplished executive with over 30 years of leadership experience in the pharmaceutical, biotechnology, and contract research organization (CRO) industries. Known for his integrity and results-driven approach, Peter has successfully led organizations through periods of significant growth and transformation. With deep expertise in drug development, clinical trials, and corporate strategy, he has built a strong reputation for driving innovation and strategic partnerships. His leadership spans notable roles, including Vice President at Optum, President of Gennaker Bio, and CEO at multiple biotech companies. Peter’s ability to communicate complex strategies and foster cross-functional collaboration has made him a respected figure in the life sciences industry.

I’m excited to share my professional biography, which reflects over 50 years of leadership, transformation, and global business impact. From guiding companies to new heights to mentoring future leaders, my journey has been fueled by a passion for creating value and sharing knowledge.

Barry M. Rosenfeld is a distinguished legal executive with extensive expertise in the biopharmaceutical and healthcare industries, known for his unwavering integrity, strategic foresight, and ability to navigate complex regulatory landscapes. With a career spanning transformative roles at Oyster Point Pharma, Novartis Group Companies, and his consultancy at B. Rosenfeld LLC, Barry has driven impactful legal strategies across corporate governance, intellectual property, product development, and M&A transactions. His deep knowledge and effective communication skills have enabled him to align legal frameworks with business objectives, guide cross-functional teams, and deliver solutions that balance risk and innovation, cementing his reputation as a trusted leader in high-stakes environments.

As a passionate advocate for innovation and patient-centered care, I’ve dedicated my career to bridging medical, economic, and regulatory landscapes to drive impactful outcomes. My experience spans over 38 years in biotechnology and pharmaceutical industries, emphasizing payer engagement, HEOR, and lifecycle management. Here is my biography.

Michael Ekstut is a seasoned business leader with over 30 years of experience in the life sciences industry, specializing in drug discovery, development, and regulatory strategy. He has held senior leadership roles at industry-leading companies, including Certara, where he guided the company’s commercial and product strategy in the regulatory and access sector. Michael is known for his strategic vision and ability to drive innovation, optimizing clinical development programs and supporting biopharma companies in navigating complex regulatory landscapes. His deep expertise in business consulting, technology, and operational management has enabled him to successfully advise executives and investors across pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Advisor at InSilicoTrials, Michael continues to leverage his vast experience to help organizations maximize the impact of their clinical development programs and investments.